Disclosures for "Investigating the Female Protective Effect in ALS: Insights from an Italian Cohort"
-
Dr. Grassano has received research support from American Brain Foundation, ALS Association and American Academy of Neurology.
-
Dr. Palumbo has nothing to disclose.
-
Cristina Moglia has nothing to disclose.
-
Dr. Mora has nothing to disclose.
-
Dr. Calvo has nothing to disclose.
-
The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.